G3 Global Awarded RM118 Million Contract to Drive Digital Transformation of KLIA and klia2
KUALA LUMPUR, May 5, 2022 – (ACN Newswire) – Artificial Intelligence (AI) specialist G3 Global…
KUALA LUMPUR, May 5, 2022 – (ACN Newswire) – Artificial Intelligence (AI) specialist G3 Global…
MOUNTAIN VIEW, Calif. and MUMBAI, India, May 5, 2022 – (ACN Newswire) – CleverTap, the…
HOUSTON–(BUSINESS WIRE)–NEXT Carbon Solutions (NCS), a subsidiary of NextDecade Corporation (NASDAQ: NEXT) and California Resources…
BOSTON–(BUSINESS WIRE)–#AccountManagement–H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $48 billion of…
Delivered consolidated revenue growth of 26.0% in the first quarter Revenue increased 7.1% excluding First…
SANTA CLARITA, Calif.–(BUSINESS WIRE)–California Resources Corporation (NYSE: CRC), an independent oil and natural gas company…
Revenue of $323 million, up 13% versus Q1 2021 Adjusted EBITDA of $68 million, up…
LONDON & SINGAPORE & NEW YORK–(BUSINESS WIRE)–Financial technology solutions provider MonetaGo has been awarded ‘best…
Record net sales of $4.9 billion, up 22% YOY Organic sales growth of 21% Record…
DENVER–(BUSINESS WIRE)–Modivcare Inc., (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that…
RALEIGH, N.C.–(BUSINESS WIRE)–Vontier Corporation (“Vontier”) (NYSE: VNT) today announced results for the first quarter 2022….
A new Fiber-to-the-Home (FTTH) modular connectivity solution by HUBER+SUHNER is the first on the market…
Novel Screening Test for Pancreatic Cancer Funded by the German Government Achieved Key Project Milestones;…
WROCŁAW, Poland, May 05, 2022 (GLOBE NEWSWIRE) — Captor Therapeutics S.A. (WSE:CTX), a biopharmaceutical company…
Ultimovacs ASA: Invitation to first quarter 2022 results webcast presentation Oslo, 5 May 2022: Ultimovacs…
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and…
Investment to Accelerate On-Going Expansion of Global Commercial Footprint PARIS, May 05, 2022 (GLOBE NEWSWIRE)…
CHF14.9M ($16.1M) of cash and cash equivalents at March 31, 2022 Dipraglurant Phase 2 blepharospasm…
Excellent progress on clinical programs Lyme Disease Vaccine Candidate VLA15 Further positive Phase 2 results…
Study met primary endpoint, demonstrating a higher proportion of sustained platelet response with VYVGART treatment…